These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian). Hodé Y; Reimold M; Demazières A; Reischl G; Bayle F; Nuss P; Hameg A; Dib M; Macher JP Psychopharmacology (Berl); 2005 Jul; 180(2):377-84. PubMed ID: 15948013 [TBL] [Abstract][Full Text] [Related]
3. Use of neuroleptic-induced extrapyramidal symptoms to predict future vulnerability to side effects. Keepers GA; Casey DE Am J Psychiatry; 1991 Jan; 148(1):85-9. PubMed ID: 1670616 [TBL] [Abstract][Full Text] [Related]
4. [Neuroleptic associated hypothermia: a new case report and study of spontaneous reports to the French pharmacovigilance network]. Huguet B; Fongue J; Chiche L; Gilly L; Pastor MJ; Michelet P; Rouby F Rev Med Interne; 2015 Feb; 36(2):124-6. PubMed ID: 24156974 [TBL] [Abstract][Full Text] [Related]
5. Incidence of extrapyramidal syndromes in AIDS patients and a comparison group of medically ill inpatients. Ramachandran G; Glickman L; Levenson J; Rao C J Neuropsychiatry Clin Neurosci; 1997; 9(4):579-83. PubMed ID: 9447500 [TBL] [Abstract][Full Text] [Related]
6. Painful sensory symptoms in neuroleptic-induced extrapyramidal syndromes. Decina P; Mukherjee S; Caracci G; Harrison K Am J Psychiatry; 1992 Aug; 149(8):1075-80. PubMed ID: 1353315 [TBL] [Abstract][Full Text] [Related]
7. Reduction of extracellular dopamine and metabolite concentrations in rat striatum by low doses of acute cyamemazine. Peinado J; Hameg A; Garay RP; Bayle F; Nuss P; Dib M Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):134-9. PubMed ID: 12595954 [TBL] [Abstract][Full Text] [Related]
8. Antipsychotics-induced ischaemic colitis and gastrointestinal necrosis: a review of the French pharmacovigilance database. Peyrière H; Roux C; Ferard C; Deleau N; Kreft-Jais C; Hillaire-Buys D; Boulenger JP; Blayac JP; Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):948-55. PubMed ID: 19572384 [TBL] [Abstract][Full Text] [Related]
9. [Therapeutic drug monitoring of cyamemazine: How to interpret a concentration? A review of literature]. Alarcan H; Schnell D; Rouleau S; Chachia A; Saint-Marcoux F; Mathieu O; Couderc S Therapie; 2022; 77(5):603-609. PubMed ID: 35221129 [TBL] [Abstract][Full Text] [Related]
10. Drugs associated with restless legs syndrome: a case/noncase study in the French Pharmacovigilance Database. Perez-Lloret S; Rey MV; Bondon-Guitton E; Rascol O; Montastruc AJ; J Clin Psychopharmacol; 2012 Dec; 32(6):824-7. PubMed ID: 23131889 [TBL] [Abstract][Full Text] [Related]
11. Recognition and management of acute neuroleptic-induced extrapyramidal motor and mental syndromes. Dose M Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():3-13. PubMed ID: 11072761 [TBL] [Abstract][Full Text] [Related]
12. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals]. Bret P; Bret MC; Queuille E Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381 [TBL] [Abstract][Full Text] [Related]
13. [Acute-onset extrapyramidal syndromes caused by drugs]. Montoya Cabrera MA; López Martín G; Baca Rodríguez LC; Porcayo Vergara F; Hernández Zamora A; Juárez Aragón G Bol Med Hosp Infant Mex; 1981; 38(4):607-15. PubMed ID: 6117295 [TBL] [Abstract][Full Text] [Related]
14. Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment. Modestin J; Wehrli MV; Stephan PL; Agarwalla P Schizophr Res; 2008 Mar; 100(1-3):97-107. PubMed ID: 18055180 [TBL] [Abstract][Full Text] [Related]
15. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia. Casey DE Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453 [TBL] [Abstract][Full Text] [Related]
16. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes. Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750 [TBL] [Abstract][Full Text] [Related]
17. Double-blind study of cyamemazine and diazepam in the alcohol withdrawal syndrome. Favre JD; Allain H; Aubin HJ; Frija-Orvoen E; Gillet C; Lejoyeux M; Payen A; Weber M; Garcia-Acosta S; Kermadi I; Dib M Hum Psychopharmacol; 2005 Oct; 20(7):511-9. PubMed ID: 16118830 [TBL] [Abstract][Full Text] [Related]
18. [Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia]. Brunot A; Lachaux B; Sontag H; Casadebaig F; Philippe A; Rouillon F; Cléry-Melin P; Hergueta T; Llorca PM; Moreaudefarges T; Guillon P; Lebrun T Encephale; 2002; 28(2):129-38. PubMed ID: 11972139 [TBL] [Abstract][Full Text] [Related]
19. [Extrapyramidal adverse effects of veralipride (Agreal), a drug used to treat hot flushes: a propos of 17 cases]. Masmoudi K; Gras-Champel V; Lemaire-Hurtel AS; Masson H; Munier A; Geslin JM; Andréjak M Rev Med Interne; 2005 Jun; 26(6):453-7. PubMed ID: 15936474 [TBL] [Abstract][Full Text] [Related]
20. [Drugs and retinal disorders: A case/non-case study in the French pharmacovigilance database]. Bourgeois N; Chavant F; Lafay-Chebassier C; Leveziel N; Pérault-Pochat MC Therapie; 2016 Sep; 71(4):365-74. PubMed ID: 27203167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]